5 reports

  • LIVER TRANSPLANT REJECTION - PIPELINE BY REDHILL BIOPHARMA LTD, H1 2017
  • LIVER TRANSPLANT REJECTION - PIPELINE BY NOVARTIS AG, H1 2018

Day ##).

  • General Medicine And Specialty Medicine
  • Liver Transplant
  • Therapy
  • United States
  • Product Initiative
  • LIVER TRANSPLANT REJECTION - PIPELINE BY DOMPE FARMACEUTICI SPA, H2 2017
  • LIVER TRANSPLANT REJECTION - PIPELINE BY CONATUS PHARMACEUTICALS INC, H2 2017

Day ##).

  • Liver Transplant
  • Therapy
  • United States
  • Product Initiative
  • Conatus Pharmaceuticals Inc.
  • Target
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Drug Discovery And Development
  • Liver Transplant
  • Transplantation
  • Novartis AG
  • LIVER TRANSPLANTATION - PIPELINE BY REDHILL BIOPHARMA LTD., H1 2016

Mechanism of Action Digna Biotech is developing cardiotrophin-## (CT-##).

  • Digestive System Disorder
  • Liver Transplant
  • Therapy
  • Transplantation
  • Novartis AG
  • LIVER TRANSPLANTATION - PIPELINE BY REDHILL BIOPHARMA LTD., H2 2015

It intends to acquire and develop late clinicalstage, proprietary drugs for the treatment of gastrointestinal and inflammatory conditions.

  • Liver Transplant
  • United States
  • Company Operations
  • Product Initiative
  • Conatus Pharmaceuticals Inc.